Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study

Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study

Abstract Background Peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-DOTA-TATE has emerged as a promising treatment for gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Its treatment protocol is currently standardised for all patients, resulting in different patient outcomes. Thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Rachele Danieli, Magdalena Mileva, Gwennaëlle Marin, Paulus Kristanto, Wendy Delbart, Bruno Vanderlinden, Zéna Wimana, Alain Hendlisz, Hugo Levillain, Nick Reynaert, Patrick Flamen, Ioannis Karfis
Format: Article
Language:English
Published: SpringerOpen 2024-11-01
Series:EJNMMI Research
Subjects:
[177Lu]Lu-DOTA-TATE
Dosimetry
Neuroendocrine tumours
Absorbed dose
GEP-NETs
Online Access:https://doi.org/10.1186/s13550-024-01163-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13550-024-01163-w

Similar Items